Nasal Mucosa Swelling During a Cold
Viral infection dilates nasal blood vessels, causing tissue swelling and blockage.
- 2-3x: Mucosal thickness (placeholder baseline swelling)
- ~60%: Airflow reduction (placeholder obstruction estimate)
- elevated: Histamine release (placeholder inflammatory signal)
- dilated: Vessel state (placeholder vascular tone)
Why the nose swells shut
Inflammation dilates vessels and leaks fluid into nasal tissue.
Placeholder: baseline swelling sets the stage for treatment.
Pseudoephedrine and Alpha-1 Receptors
Pseudoephedrine stimulates alpha-1 receptors to constrict nasal vessels.
- alpha-1: Receptor target (placeholder adrenergic subtype)
- ~30 min: Onset time (placeholder pharmacokinetics)
- -40%: Vessel diameter (placeholder constriction effect)
- 4-6 hrs: Duration (placeholder dosing interval)
How constriction happens
Placeholder: sympathomimetic action shrinks swollen vessels.
Placeholder: dose-dependent vasoconstriction reduces swelling.
Reopening the Nasal Passage
Shrunken vessels free space for air to pass through the nose again.
- restored: Lumen area (placeholder airway opening)
- +50%: Airflow gain (placeholder improvement estimate)
- lowered: Congestion score (placeholder symptom metric)
- overuse: Rebound risk (placeholder rhinitis medicamentosa note)
Airway patency improves
Placeholder: decongestion restores comfortable breathing.
Placeholder: patency rises as vessel volume drops.
Antihistamines Block Histamine Signaling
Antihistamines occupy H1 receptors, preventing histamine from triggering sneezing.
- H1: Receptor target (placeholder receptor subtype)
- reduced: Sneeze reflex (placeholder neural signal)
- lowered: Itching score (placeholder symptom metric)
- 1st-gen only: Sedation risk (placeholder side-effect note)
Competitive receptor blockade
Placeholder: antihistamines compete with histamine for H1 sites.
Placeholder: blocking H1 cuts sneezing and itch signals.
Decongestant Plus Antihistamine Together
Combining both drug classes relieves congestion, sneezing, and itching together.
- minimal: Congestion (placeholder combined outcome)
- minimal: Sneezing (placeholder combined outcome)
- high: Patency (placeholder combined outcome)
- maximal: Overall relief (placeholder combined outcome)
Synergy of combination therapy
Placeholder: combined mechanisms treat multiple cold symptoms.
Placeholder: dual therapy covers congestion and allergic signaling.